Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 29,025 AMLX shares, $932.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 29,025 | $932.6K |
| Aug 21, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 60,039 | n/a |
| Mar 9, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 248,865 | n/a |
| Mar 4, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 29,282 | $423.8K |
| Feb 4, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 15,500 | $227.6K |
| Jan 21, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Exercise/Conversion | 197,153 | $1.49M |
| Jan 8, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 7,715 | $85.6K |
| Oct 2, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 29,775 | $428.0K |
| Apr 2, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 21,490 | $74.5K |
| Mar 11, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 180,118 | n/a |